Hey Bav,
June 2024.
Ryan Witt has joined the Company (RNXT) in the new role as Senior Vice President, Head of Corporate Strategy and Partnerships.
“RenovoRx is at an important juncture, and I am excited to step into this role on a permanent basis,” said Mr. Witt. “Building off our collaboration with Imugene and clinical data delivering gemcitabine with our drug-delivery platform, there is incredible potential for RenovoRx’s technology.
"Corporate Strategy and Partnerships."
I've a lot riding on this but if I'm wrong so be it.
imo
Media Thread, page-15088
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $228.0K | 4.322M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 2146795 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 904480 | 22 |
View Market Depth
| Last trade - 12.01pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |